{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T16:32:20Z","timestamp":1761323540047,"version":"build-2065373602"},"reference-count":34,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2008,8,1]],"date-time":"2008-08-01T00:00:00Z","timestamp":1217548800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,8,1]],"date-time":"2008-08-01T00:00:00Z","timestamp":1217548800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2008,8,1]],"date-time":"2008-08-01T00:00:00Z","timestamp":1217548800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2008,8,1]],"date-time":"2008-08-01T00:00:00Z","timestamp":1217548800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2008,8,1]],"date-time":"2008-08-01T00:00:00Z","timestamp":1217548800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2008,8,1]],"date-time":"2008-08-01T00:00:00Z","timestamp":1217548800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2008,8,1]],"date-time":"2008-08-01T00:00:00Z","timestamp":1217548800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain, Behavior, and Immunity"],"published-print":{"date-parts":[[2008,8]]},"DOI":"10.1016\/j.bbi.2007.12.011","type":"journal-article","created":{"date-parts":[[2008,2,11]],"date-time":"2008-02-11T07:14:49Z","timestamp":1202714089000},"page":"881-889","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":71,"title":["Quality of life and immune activation in patients with HIV-infection"],"prefix":"10.1016","volume":"22","author":[{"given":"K.","family":"Schroecksnadel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Sarcletti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Winkler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Mumelter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Weiss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Fuchs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Kemmler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Zangerle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbi.2007.12.011_bib1","unstructured":"American Psychiatric Association, 2000. Diagnostic and Statistical Manual of Mental Disorders, fourth ed. Washington, DC (text revised)."},{"key":"10.1016\/j.bbi.2007.12.011_bib2","unstructured":"Anon., 1992. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Recomm. Rep. 41, 1\u201319."},{"key":"10.1016\/j.bbi.2007.12.011_bib3","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1097\/01.mcg.0000210099.36500.fe","article-title":"Interferon-induced depression in chronic hepatitis C: a review of its prevalence, risk factors, biology, and treatment approaches","volume":"40","author":"Asnis","year":"2006","journal-title":"J. Clin. Gastroenterol."},{"key":"10.1016\/j.bbi.2007.12.011_bib4","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.bbi.2006.02.005","article-title":"Acute psychotic symptoms in HIV-1 infected patients are associated with increased levels of kynurenic acid in cerebrospinal fluid","volume":"21","author":"Atlas","year":"2007","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.bbi.2007.12.011_bib5","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1007\/s007020070026","article-title":"Kynurenic acid metabolism in the brain of HIV-1 infected patients","volume":"107","author":"Bara","year":"2000","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.bbi.2007.12.011_bib6","doi-asserted-by":"crossref","first-page":"217","DOI":"10.2174\/138920007780362527","article-title":"How does indoleamine 2,3-dioxygenase contribute to HIV-mediated immune dysregulation","volume":"8","author":"Boasso","year":"2007","journal-title":"Curr. Drug Metab."},{"key":"10.1016\/j.bbi.2007.12.011_bib7","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/978-1-4684-5952-4_39","article-title":"Implications of interferon-induced tryptophan catabolism in cancer, auto-immune diseases and AIDS","volume":"294","author":"Brown","year":"1991","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.bbi.2007.12.011_bib8","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1017\/S1092852900023452","article-title":"Depression and HIV infection: impact on immune function and disease progression","volume":"8","author":"Cruess","year":"2003","journal-title":"CNS Spectr."},{"key":"10.1016\/j.bbi.2007.12.011_bib9","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1097\/00002030-199813000-00004","article-title":"Prognostic significance of plasma markers of immune activation, HIV viral load and CD4 T-cell measurements","volume":"12","author":"Fahey","year":"1998","journal-title":"AIDS"},{"key":"10.1016\/j.bbi.2007.12.011_bib10","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1176\/ajp.144.5.551","article-title":"Psychiatric aspects of AIDS","volume":"144","author":"Faulstich","year":"1987","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.bbi.2007.12.011_bib11","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1097\/00002030-198905000-00006","article-title":"Neopterin concentrations in cerebrospinal fluid and serum of individuals infected with HIV-1","volume":"3","author":"Fuchs","year":"1989","journal-title":"AIDS"},{"key":"10.1016\/j.bbi.2007.12.011_bib12","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/0165-2478(91)90005-U","article-title":"Increased endogenous interferon-gamma and neopterin correlate with increased degradation of tryptophan in human immunodeficiency virus type 1 infection","volume":"28","author":"Fuchs","year":"1991","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.bbi.2007.12.011_bib13","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1097\/00002030-200309050-00006","article-title":"Persistent immune activation in HIV-1 infection is associated with progression to AIDS","volume":"17","author":"Hazenberg","year":"2003","journal-title":"AIDS"},{"key":"10.1016\/j.bbi.2007.12.011_bib14","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1038\/sj.bjc.6600336","article-title":"Serum tryptophan decrease correlates with immune activation and impaired quality of life in colorectal cancer","volume":"86","author":"Huang","year":"2002","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.bbi.2007.12.011_bib15","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1084\/jem.160.1.310","article-title":"Immune response-associated production of neopterin. Release from macrophages primarily under control of interferon-gamma","volume":"160","author":"Huber","year":"1984","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bbi.2007.12.011_bib16","first-page":"233","article-title":"Cancer cachexia and depressive states: a neuro-endocrine-immunological disease?","volume":"51","author":"Iwagaki","year":"1997","journal-title":"Acta Med. Okayama"},{"key":"10.1016\/j.bbi.2007.12.011_bib17","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1089\/apc.2004.18.594","article-title":"Health-related quality of life among men with HIV infection: effects of social support, coping, and depression","volume":"18","author":"Jia","year":"2004","journal-title":"AIDS Patient Care STDS"},{"key":"10.1016\/j.bbi.2007.12.011_bib18","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1080\/000486700278","article-title":"Depressive symptoms reduced in individuals with HIV\/AIDS treated with highly active antiretroviral therapy: a longitudinal study","volume":"34","author":"Judd","year":"2000","journal-title":"Aust. N. Z. J. Psychiatry"},{"key":"10.1016\/j.bbi.2007.12.011_bib19","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1023\/A:1026114004548","article-title":"Quality of life of HIV-infected patients: psychometric properties and validation of the German version of the MQOL-HIV","volume":"12","author":"Kemmler","year":"2003","journal-title":"Qual. Life Res."},{"key":"10.1016\/j.bbi.2007.12.011_bib20","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.bbr.2003.08.008","article-title":"Behavioral effects of infection with interferon-gamma adenovector","volume":"151","author":"Kwant","year":"2004","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.bbi.2007.12.011_bib21","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/0165-1781(94)90003-5","article-title":"Increased neopterin and interferon-gamma secretion and lower availability of l-tryptophan in major depression: further evidence for an immune response","volume":"54","author":"Maes","year":"1994","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.bbi.2007.12.011_bib22","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1310\/48ET-TT7G-35RA-D4C3","article-title":"Health-related quality of life in individuals infected with HIV in the era of HAART","volume":"2","author":"Miners","year":"2001","journal-title":"HIV Clin. Trials"},{"key":"10.1016\/j.bbi.2007.12.011_bib23","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1054\/mehy.1999.1043","article-title":"Immune reaction links disease progression in cancer patients with depression","volume":"55","author":"Murr","year":"2000","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.bbi.2007.12.011_bib24","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/S0306-9877(03)00207-X","article-title":"Cytokine-serotonin interaction through IDO: a neurodegeneration hypothesis of depression","volume":"61","author":"Myint","year":"2003","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.bbi.2007.12.011_bib25","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/s00432-007-0191-3","article-title":"Diminished quality of life in patients with cancer correlates with tryptophan degradation","volume":"133","author":"Schroecksnadel","year":"2007","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.bbi.2007.12.011_bib26","doi-asserted-by":"crossref","first-page":"225","DOI":"10.2174\/138920007780362608","article-title":"Indoleamine-2,3-dioxygenase and other interferon-gamma-mediated pathways in patients with human immunodeficiency virus infection","volume":"8","author":"Schroecksnadel","year":"2007","journal-title":"Curr. Drug Metab."},{"key":"10.1016\/j.bbi.2007.12.011_bib27","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1515\/CCLM.2003.129","article-title":"Tryptophan metabolites and brain disorders","volume":"41","author":"Stone","year":"2003","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.bbi.2007.12.011_bib28","doi-asserted-by":"crossref","first-page":"2516","DOI":"10.1096\/fasebj.5.11.1907934","article-title":"Relationship between interferon-gamma, indoleamine 2,3-dioxygenase, and tryptophan catabolism","volume":"5","author":"Taylor","year":"1991","journal-title":"FASEB J."},{"key":"10.1016\/j.bbi.2007.12.011_bib29","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1046\/j.0902-4441.2003.00197.x","article-title":"Possible role of cytokine-induced tryptophan degradation in anaemia of inflammation","volume":"72","author":"Weiss","year":"2004","journal-title":"Eur. J. Haematol."},{"key":"10.1016\/j.bbi.2007.12.011_bib30","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1056\/NEJMra041809","article-title":"Anemia of chronic disease","volume":"352","author":"Weiss","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbi.2007.12.011_bib31","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1042\/bj2620861","article-title":"Parallel induction of tetrahydrobiopterin biosynthesis and indoleamine 2,3-dioxygenase activity in human cells and cell lines by interferon-gamma","volume":"262","author":"Werner","year":"1989","journal-title":"Biochem. J."},{"key":"10.1016\/j.bbi.2007.12.011_bib32","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/S0889-1591(02)00006-5","article-title":"Neopterin production, tryptophan degradation, and mental depression\u2013what is the link?","volume":"16","author":"Widner","year":"2002","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.bbi.2007.12.011_bib33","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1007\/978-1-4615-4709-9_105","article-title":"An HPLC method to determine tryptophan and kynurenine in serum simultaneously","volume":"467","author":"Widner","year":"1999","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.bbi.2007.12.011_bib34","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1006\/clim.2002.5231","article-title":"Effective antiretroviral therapy reduces degradation of tryptophan in patients with HIV-1 infection","volume":"104","author":"Zangerle","year":"2002","journal-title":"Clin. Immunol."}],"container-title":["Brain, Behavior, and Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889159107003443?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889159107003443?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T07:19:13Z","timestamp":1760167153000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889159107003443"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,8]]},"references-count":34,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2008,8]]}},"alternative-id":["S0889159107003443"],"URL":"https:\/\/doi.org\/10.1016\/j.bbi.2007.12.011","relation":{},"ISSN":["0889-1591"],"issn-type":[{"type":"print","value":"0889-1591"}],"subject":[],"published":{"date-parts":[[2008,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Quality of life and immune activation in patients with HIV-infection","name":"articletitle","label":"Article Title"},{"value":"Brain, Behavior, and Immunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbi.2007.12.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}